Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,721 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,603 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00068003 | Harvesting Cells for Experimental Cancer Treatments | enrolling by invitation | — | 7,000 | National Cancer Institute (NCI)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT07838519 | Personalizing Veterans' Lung Cancer Screening and Diagnosis(MAS-EXPAND) | enrolling by invitation | N/A | 1,400 | VA Office of Research and DevelopmentFED | 1 | Sep 24, 2026 |
| NCT04291755 | Development and Analysis of a Stool Bank for Cancer Patients | enrolling by invitation | — | 100 | Persephone BiosciencesINDUSTRY | 1 | Sep 18, 2026 | clinicaltrials |
| NCT05600933 | Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment | enrolling by invitation | — | 1,200 | National Cancer Institute (NCI)NIH | 1 | Aug 6, 2026 | clinicaltrials |
| NCT07738367 | Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC | enrolling by invitation | Phase 2 | 20 | Fujian Cancer HospitalOTHER_GOV | 1 | Jul 31, 2026 | clinicaltrials |
| NCT07373899 | Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study | enrolling by invitation | — | 354 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07218003 | A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 | enrolling by invitation | Phase 1 | 149 | Rondo TherapeuticsINDUSTRY | 1 | Jun 11, 2026 | clinicaltrials |
| NCT06885424 | A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products(DESCENT-1) | enrolling by invitation | — | 400 | A2 Biotherapeutics Inc.INDUSTRY | 1 | May 20, 2026 | clinicaltrials |
| NCT06324110 | Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial | enrolling by invitation | N/A | 6,772 | Fred Hutchinson Cancer CenterOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT03295279 | WTC Chest CT Imaging Archive | enrolling by invitation | — | 2,122 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04534413 | Ex-Vivo COF Study for Lung Cancer Observation | enrolling by invitation | — | 50 | University Health Network, TorontoOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT06281964 | Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.(KANNON-2) | enrolling by invitation | Phase 3 | 327 | Avistone Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 23, 2026 | clinicaltrials |
| NCT07494006 | Spontaneous Breathing Mode: A Risk for Hypoxemia During OLV?(OLV) | enrolling by invitation | — | 44 | Peking University People's HospitalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06730685 | Sarcopenia and Cachexia in Patients With Lung Cancer(PHILUCA) | enrolling by invitation | — | 160 | Zealand University HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07401498 | Complications Associated With Lymphadenectomy (LAD) in Surgical Treatment of Non-small Cell Lung Cancer (NSCLC).(LNDNSCLC-RUS) | enrolling by invitation | N/A | 1,000 | Regional Clinical Oncology DispensaryOTHER_GOV | 1 | Feb 10, 2026 | clinicaltrials |
| NCT06250777 | Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases(ELPIS) | enrolling by invitation | Phase 2 | 27 | Yonsei UniversityOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06332131 | Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature | enrolling by invitation | — | 25 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07390565 | YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer | enrolling by invitation | N/A | 308 | LI FENGOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07363980 | Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study(COTIRA) | enrolling by invitation | — | 4,000 | Ellen Margrethe HaugeOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07373951 | Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis(DL-DriverBM) | enrolling by invitation | — | 380 | Ming YangOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT06370416 | the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib | enrolling by invitation | Phase 2 | 41 | Henan Cancer HospitalOTHER_GOV | 1 | Jan 28, 2026 | clinicaltrials |
| NCT07307157 | Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review(COSMO) | enrolling by invitation | — | 30 | Harvard Medical School (HMS and HSDM)OTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT01385722 | Molecular Analysis of Thoracic Malignancies | enrolling by invitation | — | 1,000 | Stanford UniversityOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT07301983 | Evaluation of Lymph Node Analysis Using One Step Nucleic Acid Amplification (OSNA) in Patients With Lung Cancer Who Underwent Robotic Lung Resection, Comparison With Traditional Methods(LALC) | enrolling by invitation | — | 130 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT04945317 | ROSE for Improved Molecular Marker Testing Via EBUS(ROSE/NoROSE) | enrolling by invitation | N/A | 349 | Johns Hopkins UniversityOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT07285434 | Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer(Microlyvaq™) | enrolling by invitation | Early Phase 1 | 90 | Biogenea Pharmaceuticals Ltd.INDUSTRY | 1 | Dec 16, 2025 | clinicaltrials |
| NCT04954625 | Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial | enrolling by invitation | N/A | 60 | Rush University Medical CenterOTHER | 1 | Oct 10, 2025 | clinicaltrials |
| NCT07214441 | Evaluating the Feasibility and Preliminary Effects of BE+ | enrolling by invitation | N/A | 20 | University of South CarolinaOTHER | 1 | Oct 9, 2025 | clinicaltrials |
| NCT01460264 | An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study(BIG3) | enrolling by invitation | — | 10,000 | Region SkaneOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT07125573 | The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery | enrolling by invitation | N/A | 120 | First Affiliated Hospital of Kunming Medical UniversityOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT06391749 | Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)(K-ACCELERATE) | enrolling by invitation | — | 1,000 | Gene SolutionsINDUSTRY | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07060625 | The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery | enrolling by invitation | — | 308 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT07023068 | ⁶⁸Ga-DPA in the Lung Cancer Diagnosis | enrolling by invitation | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT06997458 | Liquid BiOpsy, Lung and Colon Cancer in AndaluciA(LOLA-PROJECT) | enrolling by invitation | — | 500 | Fundación Pública Andaluza para la Investigación Biomédica Andalucía OrientalOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT06419179 | Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)(GUIDANCE) | enrolling by invitation | Phase 2 | 29 | University of CologneOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06962449 | Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer(REALM-Post) | enrolling by invitation | — | 500 | Shanghai Chest HospitalOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT06690216 | Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors(PD-L1-PET) | enrolling by invitation | Phase 1 / Phase 2 | 100 | Man HuOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT06883136 | Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients | enrolling by invitation | — | 43 | Qianfoshan HospitalOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06876675 | LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer | enrolling by invitation | — | 167 | Peking University Third HospitalOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06848738 | Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound(IMPROVED) | enrolling by invitation | N/A | 362 | Zealand University HospitalOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06846736 | ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study(ALKDigPath) | enrolling by invitation | — | 200 | Sheba Medical CenterOTHER_GOV | 1 | Feb 26, 2025 | clinicaltrials |
| NCT06816966 | Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC(CISART) | enrolling by invitation | Phase 2 | 35 | Fujian Medical University Union HospitalOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06773156 | Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer | enrolling by invitation | Phase 2 | 37 | Second Affiliated Hospital of Nanchang UniversityOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06759857 | FHND9041 Versus Afatinib for Non-small Cell Lung Cancer(FHND9041) | enrolling by invitation | Phase 3 | 350 | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06752395 | Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions | enrolling by invitation | N/A | 200 | Pusan National University HospitalOTHER | 1 | Jan 3, 2025 | clinicaltrials |
| NCT06747832 | INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer(iNK-SCLC) | enrolling by invitation | Early Phase 1 | 10 | Guangzhou Ruixin Biotechnological Co., LTDINDUSTRY | 1 | Dec 24, 2024 | clinicaltrials |
| NCT06647836 | The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma | enrolling by invitation | — | 1,000 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06730477 | Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma | enrolling by invitation | — | 500 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT05212103 | PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9(CANSI) | enrolling by invitation | — | 30 | Turku University HospitalOTHER_GOV | 1 | Dec 4, 2024 | clinicaltrials |
| NCT06610240 | Perioperative Treatment Outcomes of Early NSCLC(Peri-R) | enrolling by invitation | — | 500 | Shanghai Chest HospitalOTHER | 1 | Nov 13, 2024 | clinicaltrials |
Data updated 24 hours agoSource updated Sep 28, 2026source: clinicaltrials